Beranda › Kolitis Ulseratif › Massachusetts
Uji klinis Kolitis Ulseratif di Massachusetts
17 studi untuk Kolitis Ulseratif mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
Menerima pesertaFase 4
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 003, Boston
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07012395A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Boston Children's Hospital, Boston
- University of Massachusetts Chan Medical School, Worcester
Menerima pesertaFase 2/3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Lucida Clinical Trials, New Bedford
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
Menerima pesertaFase 3
Usia 2 hingga 19 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Brigham and Women's Hospital, Boston
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07186101An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Tufts Medical Center - Site Number: 8400126, Boston
- UMass Memorial Medical Center - Site Number: 8400121, Worcester
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07184996Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07237516Treatment of UC With Novel Therapeutics
- Brigham and Women's Hospital, Chestnut Hill
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT06420375A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Boston Children's Hospital, Boston
Menerima pesertaFase 2
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT05287126A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400017, Boston
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT06975722Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Massachusetts General Hospital, Boston
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 8 Jan 2026 · NCT05987852Study of Novel Therapeutics for Acute Remedy of Colitis
- Brigham and Women's Hospital, Chestnut Hill
- Brigham and Women's Hospital, Chestnut Hill
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT06420492High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
Menerima pesertaStudi observasional
Usia 5 hingga 25 · Semua jenis kelamin · Diperbarui 3 Mar 2025 · NCT04331639Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 14 ke atas · Semua jenis kelamin · Diperbarui 20 Des 2024 · NCT06655415Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.